GCT’s Historic Potential | Priorities and Trade Offs - World Medical Innovation Forum
WMIF Main Site

GCT’s Historic Potential | Priorities and Trade Offs

GCT’s Historic Potential | Priorities and Trade Offs

Monday, May 2, 2022

2:00 PM – 2:40 PM America Ballroom View Here

This panel features industry leaders who will discuss what the future may hold for gene and cell therapy. Which applications are likely to have the greatest impact? What are the key hurdles to be overcome? What specific platforms and technologies may enable optimal solutions? In what disease areas? Learn more about these and other questions as the panelists discuss the future potential of GCT.

Moderator:
Jean-François Formela, MD
  • Partner, Atlas Venture
Panelists:
Pablo Cagnoni, MD
  • CEO, Rubius Therapeutics
Kristen Hege, MD
  • Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, Bristol Myers Squibb
Andrew Plump, MD, PhD
  • President, R&D, Takeda
Catherine Stehman-Breen, MD
  • CEO, Chroma Medicine

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA